Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2022.05 -13.85 (-0.68%) | NSE 2023.40 -11.80 (-0.58%) | Trade | Add

BSE Live

Jan 01, 10:03

2022.05 -13.85 (-0.68%)

Volume

AVERAGE VOLUME

5-Day

14,714

10-Day

15,431

30-Day

18,088

1,998

Prev. Close

2035.90
Open Price

2018.30

Bid Price (Qty.)
2021.95 (49)
Offer Price (Qty.)
2024.25 (6)

NSE Live

Jan 01, 10:03

2023.40 -11.80 (-0.58%)

Volume

AVERAGE VOLUME

5-Day

743,652

10-Day

699,904

30-Day

740,441

24,331

Prev. Close

2035.20
Open Price

2034.00

Bid Price (Qty.)
2023.40 (18)
Offer Price (Qty.)
2024.10 (228)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	0.00	7.65	25.41	25.83	7.41
Diluted EPS (Rs.)	0.00	7.65	25.41	25.83	7.41
Cash EPS (Rs.)	0.00	11.85	28.33	29.51	9.45
Book Value [ExclRevalReserve]/Share (Rs.)	0.00	63.92	61.09	57.17	31.43
Book Value [InclRevalReserve]/Share (Rs.)	0.00	63.92	61.09	57.17	31.43
Revenue from Operations/Share (Rs.)	0.00	84.47	79.61	101.96	59.33
PBDIT/Share (Rs.)	0.00	25.32	34.34	36.93	12.93
PBIT/Share (Rs.)	0.00	21.22	31.46	33.41	10.97
PBT/Share (Rs.)	0.00	15.40	28.61	30.10	9.44
Net Profit/Share (Rs.)	0.00	7.72	25.41	25.83	7.41
NP After MI And SOA / Share (Rs.)	0.00	7.65	25.41	25.83	7.41
Profitability Ratios
PBDIT Margin (%)	0.00	29.97	43.14	36.22	21.78
PBIT Margin (%)	0.00	25.11	39.52	32.77	18.48
PBT Margin (%)	0.00	18.23	35.93	29.51	15.91
Net Profit Margin (%)	0.00	9.14	31.92	25.33	12.48
NP After MI And SOA Margin (%)	0.00	9.05	31.92	25.33	12.48
Return on Networth/Equity (%)	0.00	11.99	41.64	45.17	23.57
Return on Capital Employed (%)	0.00	9.64	33.64	25.28	9.08
Return on Assets (%)	0.00	4.50	21.46	15.95	6.51
Total Debt/Equity (X)	0.00	1.31	0.65	1.36	1.97
Asset Turnover Ratio (%)	0.00	49.70	67.21	62.97	52.12
Liquidity Ratios
Current Ratio (X)	0.00	0.92	1.55	1.54	1.94
Quick Ratio (X)	0.00	0.64	1.17	1.17	1.53
Inventory Turnover Ratio (X)	0.00	3.36	4.94	4.54	4.47
Dividend Payout Ratio (NP) (%)	0.00	5.22	2.71	3.08	9.44
Dividend Payout Ratio (CP) (%)	0.00	3.39	2.43	2.70	7.41
Earnings Retention Ratio (%)	0.00	94.78	97.29	96.92	90.56
Cash Earnings Retention Ratio (%)	0.00	96.61	97.57	97.30	92.59
Coverage Ratios
Interest Coverage Ratios (%)	--	3.65	11.02	10.07	7.17
Interest Coverage Ratios (Post Tax) (%)	--	3.65	11.02	10.07	7.17
Valuation Ratios
Enterprise Value (Cr.)	0.00	5,974.64	13,037.82	8,150.83	4,379.98
EV/Net Operating Revenue (X)	0.00	2.82	6.58	6.66	6.22
EV/EBITDA (X)	0.00	9.42	15.26	18.38	28.54
MarketCap/Net Operating Revenue (X)	0.00	1.87	6.16	5.98	5.30
Retention Ratios (%)	0.00	94.77	97.28	96.91	90.55
Price/BV (X)	0.00	2.47	8.04	10.67	10.00
Price/Net Operating Revenue	0.00	1.87	6.16	5.98	5.30
Earnings Yield	0.00	0.05	0.05	0.04	0.02